Ifp Advisors, Inc Sarepta Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,435 shares of SRPT stock, worth $163,920. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,435

Previous 1,335 7.49%

Holding current value

$163,920

Previous $172,000 31.4%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$113.33 - $163.85 $11,333 - $16,385	100 Added 7.49%	1,435 $226,000
Q1 2024 Jul 30, 2024	SELL	$93.7 - $141.53 $843 - $1,273	-9 Reduced 0.67%	1,335 $172,000
Q4 2023 Jan 09, 2024	BUY	$67.31 - $124.76 $15,346 - $28,445	228 Added 20.43%	1,344 $129,000
Q3 2023 Oct 12, 2023	SELL	$102.5 - $123.59 $410 - $494	-4 Reduced 0.36%	1,116 $135,000
Q2 2023 Aug 04, 2023	BUY	$106.4 - $157.19 $118,529 - $175,109	1,114 Added 18566.67%	1,120 $128,000
Q1 2023 Apr 18, 2023	SELL	$117.53 - $155.99 $25,033 - $33,225	-213 Reduced 97.26%	6 $0
Q3 2022 Nov 08, 2022	BUY	$75.71 - $119.24 $15,141 - $23,848	200 Added 1052.63%	219 $21,000
Q2 2022 Sep 06, 2022	BUY	$62.69 - $88.44 $1,191 - $1,680	19 New	19 $2,000
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $1,191 - $1,680	-19 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$63.15 - $90.42 $568 - $813	-9 Reduced 32.14%	19 $1,000
Q3 2021 Oct 06, 2021	BUY	$65.97 - $92.48 $1,781 - $2,496	27 Added 2700.0%	28 $4,000
Q2 2021 Jul 13, 2021	BUY	$69.38 - $86.75 $69 - $86	1 New	1 $0
Q1 2021 Apr 30, 2021	SELL	$72.25 - $168.95 $650 - $1,520	-9 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $837 - $1,545	9 New	9 $1,000
Q1 2020 May 12, 2020	BUY	$82.38 - $131.64 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$76.53 - $135.58 $38,265 - $67,790	-500 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$72.81 - $156.91 $35,604 - $76,728	489 Added 4445.45%	500 $38,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $77,975 - $110,878	-731 Reduced 98.52%	11 $2,000
Q4 2018 Jan 23, 2019	SELL	$97.32 - $148.76 $88,755 - $135,669	-912 Reduced 55.14%	742 $80,000
Q3 2018 Oct 25, 2018	BUY	$115.31 - $161.51 $54,656 - $76,555	474 Added 40.17%	1,654 $0
Q2 2018 Aug 07, 2018	SELL	$71.74 - $153.69 $19,441 - $41,649	-271 Reduced 18.68%	1,180 $0
Q1 2018 Jun 03, 2019	BUY	$54.02 - $82.27 $4,861 - $7,404	90 Added 6.61%	1,451 $81,000
Q1 2018 May 09, 2018	SELL	$54.02 - $82.27 $4,861 - $7,404	-90 Reduced 6.2%	1,361 $0
Q4 2017 Jan 24, 2018	SELL	$47.64 - $56.75 $13,386 - $15,946	-281 Reduced 16.22%	1,451 $0
Q3 2017 Oct 30, 2017	BUY	$35.73 - $47.15 $7,574 - $9,995	212 Added 13.95%	1,732 $79,000
Q2 2017 Jun 03, 2019	BUY	N/A	715 Added 88.82%	1,520 $51,000
Q1 2017 Jun 03, 2019	SELL	N/A	-616 Reduced 43.35%	805 $24,000
Q4 2016 Jun 03, 2019	SELL	N/A	-2,629 Reduced 64.91%	1,421 $39,000
Q2 2016 Jun 03, 2019	BUY	N/A	4,039 Added 36718.18%	4,050 $77,000
Q1 2016 Jun 03, 2019	BUY	N/A	11	11 $2,000

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account